FDA Inspection 972163 — AbbVie Bioresearch Center

AbbVie Bioresearch Center — FEI 3003684386

The FDA completed an inspection of AbbVie Bioresearch Center on April 20, 2016 in Worcester, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 20, 2016
Fiscal Year
2016
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Worcester, MA (United States)